Nutex Health Inc. NUTX
220.11
15.52
7.59%
as of 25 Sep
- Market cap
- $1.4B
- P/E
- 8.4×
Follow NUTX
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 42.63% | 27.64% | 23.13% | 46.57% |
+8 more TTM periods Free account |
|
| 19.93% | 11.21% | 9.00% | 17.19% | ||
ROIC |
37.92% | 31.89% | 32.12% | 37.97% | |
Return on Tangible Assets |
31.89% | 19.66% | 14.89% | 24.60% | |
Average Days of Receivables |
153.76 | 143.48 | 135.71 | 151.35 | |
Free Cash Flow per Share |
39.90 | 38.49 | 38.61 | 26.31 | |
Free Cash Flow |
274.17 | 269.02 | 245.60 | 176.28 | |
Capital Expenditures |
(5.45) | (3.66) | (2.53) | (1.51) | |
Piotroski F-Score |
6.00 | 5.00 | 7.00 | 8.00 | |
| Other line items | |||||
Cash ROIC |
27.56% | 28.33% | 27.32% | 19.26% | |
Accounts Receivable Turnover |
2.38 | 2.73 | 3.12 | 4.15 | |
Accounts Payable Turnover |
20.63 | 12.78 | 14.51 | 13.33 | |
Inventory Turnover |
127.33 | 118.58 | 150.80 | 162.97 | |
Average Days of Payables |
8.81 | 39.77 | 41.47 | 40.98 | |
Days of Inventory on Hand |
3.72 | 3.69 | 2.43 | 2.61 | |
Tax Rate |
(0.21) | (0.23) | (0.26) | (0.20) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.24% | 16.07% | 19.27% | 18.43% | |
Share Based Compensation of Revenue |
1.13% | 9.71% | 13.37% | 13.68% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.55 | 2.83 | 3.51 | 1.47 | |
Depreciation/Fixed assets |
0.22 | 0.22 | 0.22 | 0.25 | |
Capex/Depreciation |
(0.26) | (0.17) | (0.12) | (0.07) | |
Revenue per Share |
123.23 | 125.89 | 137.59 | 146.42 | |
Operating CF per Share |
40.70 | 39.01 | 39.00 | 26.53 | |
Capex per Share |
(0.79) | (0.52) | (0.40) | (0.23) | |
Capex to Sales |
0.01 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
21.25% | 10.95% | 8.09% | 12.29% |
Columns are period end dates